# Jocasta Neuroscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jocasta-neuroscience

- Industry: Biotechnology
- Headquarters: Northbrook, US
- Website: www.jocastaneuro.com
- Total disclosed funding: $35M
- Latest round: Series A (Aug 12, 2025)
- Investors on record: 2

## About

Based in Illinois, US and founded in 2021, Jocasta Neuroscience, Inc. operates as a biotechnology company that provides healthcare services. In October 2024, Jocasta Neuroscience, Inc. raised USD 31.65 million in venture funding.  Jocasta Neuroscience, Inc. is a biotech firm focused on developing protein as a potential treatment for cognitive decline related to various forms of dementia. In August 2025, Jocasta Neuroscience, Inc. raised USD 35 million in series A funding led by new investor True Ventures, with participation from other new investors Moore Strategic Ventures, SC8 Investments, and Yagan Family Foundation. Individual and other unspecified investors also participated in the round. The company will use the funding to test a new protein medicine that may help people with memory problems caused by brain diseases.

## Funding rounds

- Series A, Aug 12, 2025, $35M — True Ventures, Moore Strategic Ventures

## Investors

- True Ventures (https://capitalatlas.ai/funds/true-ventures) — Series A
- Moore Strategic Ventures (https://capitalatlas.ai/funds/moore-strategic-ventures) — Series A